5-HT1A modulator 1 is used as a potent antagonist at the 5-HT2A receptor subtype, effectively blocking stereotypies and climbing behavior in mice at a dose of 1 mg/kg (ip); it also significantly reduces hyperactivity in rats after oral administration, showing dose-dependent antagonism (50% reduction at 2–4 mg/kg po, and complete antagonism at 8–16 mg/kg po).